Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry

被引：0

作者：

Casanova, M. J. ^{[1
,2
]}

Chaparro, M. ^{[1
,2
]}

Minguez, M. ^{[3
]}

Ricart, E. ^{[4
,5
]}

Taxonera, C. ^{[6
]}

Garcia-Lopez, S. ^{[7
,8
]}

Guardiola, J. ^{[9
]}

Lopez-San Roman, A. ^{[10
]}

Iglesias, E. ^{[11
]}

Beltran, B. ^{[12
,13
]}

Sicilia, B. ^{[14
]}

Vera, M. I. ^{[15
]}

Hinojosa, J. ^{[16
]}

Riestra, S. ^{[17
]}

Domenech, E. ^{[18
,19
]}

Calvet, X. ^{[20
,21
]}

Perez-Calle, J. L. ^{[22
]}

Martin-Arranz, M. D. ^{[23
,24
]}

Aldeguer, X. ^{[25
]}

Rivero, M. ^{[26
,27
]}

Monfort, D. ^{[28
]}

Barrio, J. ^{[29
]}

Esteve, M. ^{[30
]}

Marquez, L. ^{[31
]}

Lorente, R. ^{[32
,33
]}

Garcia-Planella, E. ^{[34
]}

de Castro, L. ^{[35
]}

Bermejo, F. ^{[36
,37
]}

Merino, O. ^{[38
]}

Rodriguez-Perez, A. ^{[39
]}

Martinez-Montiel, P. ^{[40
]}

Van Domselaar, M. ^{[41
]}

Alcain, G. ^{[42
]}

Dominguez-Cajal, M. ^{[43
]}

Munoz, C. ^{[44
]}

Gomollon, F. ^{[45
]}

Fernandez-Salazar, L. ^{[46
]}

Garcia-Sepulcre, M. F. ^{[47
]}

Rodriguez-Lago, I. ^{[48
]}

Gutierrez, A. ^{[49
,50
]}

Arguelles-Arias, F. ^{[51
]}

Rodriguez, C. ^{[52
]}

Rodriguez, G. E. ^{[53
]}

Bujanda, L. ^{[54
,55
]}

Llao, J. ^{[56
]}

Varela, P. ^{[57
]}

Ramos, L. ^{[58
]}

Huguet, J. M. ^{[59
]}

Almela, P. ^{[60
]}

Romero, P. ^{[61
]}

机构：

[1] Univ Autonoma Madrid, Hosp Univ Princesa, IIS IP, Madrid, Spain

[2] CIBEREHD, Gastroenterol Unit, Madrid, Spain

[3] Hosp Clin Univ Valencia, Gastroenterol Unit, Valencia, Spain

[4] Hosp Clin Barcelona, CIBEREHD, Barcelona, Spain

[5] IDIBAPS, Gastroenterol Unit, Barcelona, Spain

[6] Hosp Univ Clin San Carlos, Gastroenterol Unit, Madrid, Spain

[7] Hosp Univ Miguel Servet, Zaragoza, Spain

[8] CIBEREHD, Gastroenterol Unit, Zaragoza, Spain

[9] Hosp Univ Bellvitge, Gastroenterol Unit, Barcelona, Spain

[10] Hosp Univ Ramon y Cajal, Gastroenterol Unit, Madrid, Spain

[11] Hosp Univ Reina Sofia, Gastroenterol Unit, Cordoba, Spain

[12] Hosp Univ & Politecn La Fe, Valencia, Spain

[13] CIBEREHD, Gastroenterol Unit, Valencia, Spain

[14] Hosp Univ Burgos, Gastroenterol Unit, Burgos, Spain

[15] Hosp Univ Puerta Hierro Majadahonda, Gastroenterol Unit, Madrid, Spain

[16] Hosp Manises, Gastroenterol Unit, Valencia, Spain

[17] Hosp Univ Cent Asturias, Gastroenterol Unit, Oviedo, Spain

[18] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[19] CIBEREHD, Gastroenterol Unit, Badalona, Spain

[20] Corporacio Sanitaria Univ Parc Tauli, Hosp Sabadell, Sabadell, Spain

[21] CIBEREHD, Gastroenterol Unit, Sabadell, Spain

[22] Hosp Univ Fdn Alcorcon, Gastroenterol Unit, Madrid, Spain

[23] Hosp Univ La Paz, Madrid, Spain

[24] Inst Invest La Paz IdiPaz, Gastroenterol Unit, Madrid, Spain

[25] Hosp Univ Girona Dr Josep Trueta, Gastroenterol Unit, Girona, Spain

[26] Hosp Univ Marques Valdecilla, Santander, Spain

[27] IDIVAL, Gastroenterol, Santander, Spain

[28] Consorci Sanitari Terrassa, Gastroenterol, Tarrasa, Spain

[29] Hosp Univ Rio Hortega, Gastroenterol, Valladolid, Spain

[30] Hosp Univ Mutua Terrasa, Gastroenterol Unit, Tarrasa, Spain

[31] Hosp del Mar, Gastroenterol Unit, Barcelona, Spain

[32] Hosp Gen Univ Ciudad Real, Ciudad Real, Spain

[33] CIBEREHD, Gastroenterol Unit, Ciudad Real, Spain

[34] Hosp Santa Creu & Sant Pau, Gastroenterol Unit, Barcelona, Spain

[35] Complejo Hosp Univ Vigo, Gastroenterol Unit, Vigo, Spain

[36] Hosp Univ Fuenlabrada, Madrid, Spain

[37] Inst Invest La Paz IdiPaz, Gastroenterol Unit, Madrid, Spain

[38] Hosp Univ Cruces, Baracaldo, Spain

[39] Hosp Clin Univ Salamanca, Gastroenterol Unit, Salamanca, Spain

[40] Hosp Univ Doce Octubre, Gastroenterol Unit, Madrid, Spain

[41] Hosp Torrejon, Gastroenterol Unit, Madrid, Spain

[42] Hosp Univ Virgen Victoria, Gastroenterol Unit, Malaga, Spain

[43] Hosp Gen San Jorge, Gastroenterol Unit, Huesca, Spain

[44] Hosp Basurto, Gastroenterol Unit, Bilbao, Spain

[45] Hosp Clin Univ Lozano Blesa, Gastroentero Unit, Zaragoza, Spain

[46] Hosp Clin Univ Valladolid, Gastroenterol Unit, Valladolid, Spain

[47] Hosp Gen Univ Elche, Gastroenterol Unit, Elche, Spain

[48] Hosp Galdakao Usansolo, Gastroenterol Unit, Galdakao, Spain

[49] Hosp Gen Univ Alicante, Alicante, Spain

[50] CIBEREHD, Gastroenterol Unit, Alicante, Spain

来源：

JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷

关键词：

D O I：

10.1093/ecco-jcc/jjy222.563

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P439

引用

页码：S329 / S330

页数：3

共 50 条

[11] Strategic Use of Immunosuppressants and Anti-TNF in Inflammatory Bowel Disease
Louis, Edouard
DIGESTIVE DISEASES, 2013, 31 (02) : 207 - 212
[12] Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry
Hernandez-Camba, A.
Arranz, L.
Vera, I
Carpio, D.
Calafat, M.
Lucendo, A. J.
Taxonera, C.
Marin, S.
Garcia, M. J.
Marin, G. Suris
Rodriguez, E. Sanchez
Carbajo, A. Y.
De Castro, M. L.
Iborra, M.
Martin-Cardona, A.
Rodriguez-Lago, I
Busquets, D.
Bertoletti, F.
Ausin, M. Sierra
Tardillo, C.
Malaves, J. Huguet
Bujanda, L.
Castano, A.
Domenech, E.
Ramos, L.
DIGESTIVE AND LIVER DISEASE, 2022, 54 (05) : 635 - 641
[13] Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
Chanchlani, Neil
Lin, Simeng
Auth, Marcus K.
Lee, Chai Leng
Robbins, Helena
Looi, Shi
Murugesan, Senthil, V
Riley, Tom
Preston, Cathryn
Stephenson, Sophie
Cardozo, Wendy
Sonwalkar, Sunil A.
Allah-Ditta, Mohammed
Mansfield, Lynne
Durai, Dharmaraj
Baker, Mark
London, Ian
London, Emily
Gupta, Sanjay
Di Mambro, Alex
Murphy, Aisling
Gaynor, Edward
Jones, Kelsey D. J.
Claridge, Andrew
Sebastian, Shaji
Ramachandran, Sankaranarayanan
Selinger, Christian P.
Borg-Bartolo, Simon P.
Knight, Paul
Sprakes, Michael B.
Burton, Julie
Kane, Patricia
Lupton, Stephanie
Fletcher, Aimee
Gaya, Daniel R.
Colbert, Roghan
Seenan, John Paul
MacDonald, Jonathan
Lynch, Lucy
McLachlan, Iain
Shields, Stephanie
Hansen, Richard
Gervais, Lisa
Jere, Mwansa
Akhtar, Muhammad
Black, Karen
Henderson, Paul
Russell, Richard K.
Lees, Charlie W.
Derikx, Lauranne A. A. P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1250 - 1263
[14] Anti-TNF alpha therapy in Inflammatory Bowel Disease - safety profile in elderly patients
Bernardes, C.
Carvalho, D.
Russo, P.
Saiote, J.
Ramos, J.
JOURNAL OF CROHNS & COLITIS, 2015, 9 : S400 - S400
[15] Elderly patients with inflammatory bowel disease under anti-TNF therapy: efficacy and safety
Ortega, T. Lobaton
Vermeire, S.
Ballet, V.
Rutgeerts, P.
Van Assche, G.
Ferrante, M.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S273 - S273
[16] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
Khan, Nabeel
Asim, Hamna
Lichtenstein, Gary R.
EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708
[17] Use of a third anti-TNF after failure of two previous anti-TNFs in patients with inflammatory bowel disease: is it worth it?
Gisbert, Javier P.
Chaparro, Maria
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (04) : 379 - 386
[18] Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Calafat, Margalida
Torres, Paola
Tosca-Cuquerella, Joan
Sanchez-Aldehuelo, Ruben
Rivero, Montserrat
Iborra, Marisa
Gonzalez-Vivo, Maria
Vera, Isabel
de Castro, Luisa
Bujanda, Luis
Barreiro-de Acosta, Manuel
Gonzalez-Munoza, Carlos
Calvet, Xavier
Benitez, Jose Manuel
Llorente-Barrio, Monica
Suris, Gerard
Canete, Fiorella
Arias-Garcia, Lara
Monfort, David
Castano-Garcia, Andres
Garcia-Alonso, Francisco Javier
Huguet, Jose M.
Marin-Jimenez, Ignacio
Lorente, Rufo
Martin-Cardona, Albert
Ferrer, Juan Angel
Camo, Patricia
Gisbert, Javier P.
Pajares, Ramon
Gomollon, Fernando
Castro-Poceiro, Jesus
Morales-Alvarado, Jair
Llao, Jordina
Rodriguez, Andres
Rodriguez, Cristina
Perez-Galindo, Pablo
Navarro, Merce
Jimenez-Garcia, Nuria
Carrillo-Palau, Marta
Blazquez-Gomez, Isabel
Sese, Eva
Almela, Pedro
Ramirez de la Piscina, Patricia
Taxonera, Carlos
Rodriguez-Lago, Iago
Cabrinety, Lidia
Vela, Milagros
Minguez, Miguel
Mesonero, Francisco
Garcia, Maria Jose
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
[19] ANTI-TNF INDUCED LYMPHOCYTOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Soufleris, Konstantinos
Kafalis, Nikolaos
Fasoulas, Konstantinos
Pilpilidis, Ioannis
Lazaraki, Georgia
Markala, Dimitra
Tzilves, Dimitris
GASTROENTEROLOGY, 2019, 156 (06) : S635 - S635
[20] Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease
Strik, A. S.
Bots, S. J. A.
D'Haens, G.
Lowenberg, M.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 429 - 439

← 1 2 3 4 5 →